Literature DB >> 21235308

Theta-gamma dysrhythmia and auditory phantom perception.

Dirk De Ridder1, Elsa van der Loo, Sven Vanneste, Steffen Gais, Mark Plazier, Silvia Kovacs, Stefan Sunaert, Tomas Menovsky, Paul van de Heyning.   

Abstract

Tinnitus is considered an auditory phantom percept analogous to phantom pain. Thalamocortical dysrhythmia has been proposed as a possible pathophysiological mechanism for both tinnitus and pain. Thalamocortical dysrhythmia refers to a persistent pathological resting state theta-gamma coupling that is spatially localized at an area where normally alpha oscillations predominate. Auditory cortex stimulation via implanted electrodes has been developed to treat tinnitus, targeting an area of activation on functional MR imaging elicited by tinnitus-matched sound presentation. The authors describe a case in which clinical improvement was correlated with changes in intracranial recordings. Maximal tinnitus suppression was obtained by current delivery exactly at the blood oxygen level-dependent activation hotspot, which colocalizes with increased gamma and theta activity, in contrast to the other electrode poles, which demonstrated a normal alpha peak. These spectral changes normalized when stimulation induced tinnitus suppression, both on electrode and source-localized electroencephalography recordings. These data suggest that thetagamma coupling as proposed by the thalamocortical dysrhythmia model might be causally related to a conscious auditory phantom percept.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235308     DOI: 10.3171/2010.11.JNS10335

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  37 in total

1.  Phantom percepts: tinnitus and pain as persisting aversive memory networks.

Authors:  Dirk De Ridder; Ana Belen Elgoyhen; Ranulfo Romo; Berthold Langguth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

Review 2.  Auditory thalamic circuits and GABAA receptor function: Putative mechanisms in tinnitus pathology.

Authors:  Donald M Caspary; Daniel A Llano
Journal:  Hear Res       Date:  2016-08-21       Impact factor: 3.208

3.  The differential effect of low- versus high-frequency random noise stimulation in the treatment of tinnitus.

Authors:  Kathleen Joos; Dirk De Ridder; Sven Vanneste
Journal:  Exp Brain Res       Date:  2015-02-19       Impact factor: 1.972

Review 4.  Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.

Authors:  Andrew F Leuchter; Aimee M Hunter; David E Krantz; Ian A Cook
Journal:  Ann N Y Acad Sci       Date:  2015-03-23       Impact factor: 5.691

Review 5.  No Laughing Matter: Gelastic Migraine and Other Unusual Headache Syndromes.

Authors:  Paul G Mathew; Carrie E Robertson
Journal:  Curr Pain Headache Rep       Date:  2016-05

Review 6.  Neuromodulation for tinnitus treatment: an overview of invasive and non-invasive techniques.

Authors:  Nicole Peter; Tobias Kleinjung
Journal:  J Zhejiang Univ Sci B       Date:  2018-03-12       Impact factor: 3.066

7.  Top-down and Bottom-up Regulated Auditory Phantom Perception.

Authors:  Sven Vanneste; Ola Alsalman; Dirk De Ridder
Journal:  J Neurosci       Date:  2018-11-02       Impact factor: 6.167

Review 8.  Neuromodulation: selected approaches and challenges.

Authors:  Vladimir Parpura; Gabriel A Silva; Peter A Tass; Kevin E Bennet; M Meyyappan; Jessica Koehne; Kendall H Lee; Russell J Andrews
Journal:  J Neurochem       Date:  2012-12-26       Impact factor: 5.372

9.  EEG Driven tDCS Versus Bifrontal tDCS for Tinnitus.

Authors:  Dirk De Ridder; Sven Vanneste
Journal:  Front Psychiatry       Date:  2012-09-25       Impact factor: 4.157

Review 10.  Auditory thalamus dysfunction and pathophysiology in tinnitus: a predictive network hypothesis.

Authors:  Pia Brinkmann; Sonja A Kotz; Jasper V Smit; Marcus L F Janssen; Michael Schwartze
Journal:  Brain Struct Funct       Date:  2021-05-02       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.